Effect of cerium oxide on erythrocyte deformability in rat lower extremity ischemia reperfusion injury

Cerium oxide is the oxide form of cerium, which has protective effects in ischemia reperfusion (I/R) injury. The purpose of our study was to look into the effects of this rare-earth metal on erythrocyte deformability in rat lower extremity I/R injury model. We used 24 Wistar albino rats as subjects...

Full description

Saved in:
Bibliographic Details
Published inBratislavské lékarské listy Vol. 119; no. 7; p. 441
Main Authors Tatar, T, Polat, Y, Comu, F M, Kartal, H, Arslan, M, Kucuk, A
Format Journal Article
LanguageEnglish
Published Slovakia 2018
Subjects
Online AccessGet full text
ISSN0006-9248
DOI10.4149/BLL_2018_080

Cover

Abstract Cerium oxide is the oxide form of cerium, which has protective effects in ischemia reperfusion (I/R) injury. The purpose of our study was to look into the effects of this rare-earth metal on erythrocyte deformability in rat lower extremity I/R injury model. We used 24 Wistar albino rats as subjects in our study. They were divided into 4 groups; randomized control group (group C; n = 6), cerium oxide group 0.5 mg.kg-1, intraperitoneal (group CO; n = 6), I/R group (group I/R; n = 6) and I/R group with cerium oxide 0.5 mg.kg-1 intraperitoneally (group I/R-CO; n = 6). Erythrocyte packs were prepared from heparinized blood samples and deformability measurements were performed. We obtained similar results from the control and I/R-CO groups (p = 0.158). The results in I/R group were evidently higher than those of the control, CO, and IR-CO groups (p < 0.0001, p < 0.0001, p = 0.001, respectively). We detected unfavorable effects of I/R on erythrocyte deformability, which may impair blood flow and hence tissue perfusion in infrarenal rat aorta. We also found that cerium oxide had beneficial effects by reversing undesirable effects of I/R. Further studies with larger volume are required to support our promising results (Fig. 1, Ref. 24).
AbstractList Cerium oxide is the oxide form of cerium, which has protective effects in ischemia reperfusion (I/R) injury. The purpose of our study was to look into the effects of this rare-earth metal on erythrocyte deformability in rat lower extremity I/R injury model. We used 24 Wistar albino rats as subjects in our study. They were divided into 4 groups; randomized control group (group C; n = 6), cerium oxide group 0.5 mg.kg-1, intraperitoneal (group CO; n = 6), I/R group (group I/R; n = 6) and I/R group with cerium oxide 0.5 mg.kg-1 intraperitoneally (group I/R-CO; n = 6). Erythrocyte packs were prepared from heparinized blood samples and deformability measurements were performed. We obtained similar results from the control and I/R-CO groups (p = 0.158). The results in I/R group were evidently higher than those of the control, CO, and IR-CO groups (p < 0.0001, p < 0.0001, p = 0.001, respectively). We detected unfavorable effects of I/R on erythrocyte deformability, which may impair blood flow and hence tissue perfusion in infrarenal rat aorta. We also found that cerium oxide had beneficial effects by reversing undesirable effects of I/R. Further studies with larger volume are required to support our promising results (Fig. 1, Ref. 24).
Cerium oxide is the oxide form of cerium, which has protective effects in ischemia reperfusion (I/R) injury. The purpose of our study was to look into the effects of this rare-earth metal on erythrocyte deformability in rat lower extremity I/R injury model.BACKGROUNDCerium oxide is the oxide form of cerium, which has protective effects in ischemia reperfusion (I/R) injury. The purpose of our study was to look into the effects of this rare-earth metal on erythrocyte deformability in rat lower extremity I/R injury model.We used 24 Wistar albino rats as subjects in our study. They were divided into 4 groups; randomized control group (group C; n = 6), cerium oxide group 0.5 mg.kg-1, intraperitoneal (group CO; n = 6), I/R group (group I/R; n = 6) and I/R group with cerium oxide 0.5 mg.kg-1 intraperitoneally (group I/R-CO; n = 6). Erythrocyte packs were prepared from heparinized blood samples and deformability measurements were performed.MATERIALS AND METHODSWe used 24 Wistar albino rats as subjects in our study. They were divided into 4 groups; randomized control group (group C; n = 6), cerium oxide group 0.5 mg.kg-1, intraperitoneal (group CO; n = 6), I/R group (group I/R; n = 6) and I/R group with cerium oxide 0.5 mg.kg-1 intraperitoneally (group I/R-CO; n = 6). Erythrocyte packs were prepared from heparinized blood samples and deformability measurements were performed.We obtained similar results from the control and I/R-CO groups (p = 0.158). The results in I/R group were evidently higher than those of the control, CO, and IR-CO groups (p < 0.0001, p < 0.0001, p = 0.001, respectively).RESULTSWe obtained similar results from the control and I/R-CO groups (p = 0.158). The results in I/R group were evidently higher than those of the control, CO, and IR-CO groups (p < 0.0001, p < 0.0001, p = 0.001, respectively).We detected unfavorable effects of I/R on erythrocyte deformability, which may impair blood flow and hence tissue perfusion in infrarenal rat aorta. We also found that cerium oxide had beneficial effects by reversing undesirable effects of I/R. Further studies with larger volume are required to support our promising results (Fig. 1, Ref. 24).CONCLUSIONWe detected unfavorable effects of I/R on erythrocyte deformability, which may impair blood flow and hence tissue perfusion in infrarenal rat aorta. We also found that cerium oxide had beneficial effects by reversing undesirable effects of I/R. Further studies with larger volume are required to support our promising results (Fig. 1, Ref. 24).
Author Tatar, T
Polat, Y
Arslan, M
Kucuk, A
Comu, F M
Kartal, H
Author_xml – sequence: 1
  givenname: T
  surname: Tatar
  fullname: Tatar, T
– sequence: 2
  givenname: Y
  surname: Polat
  fullname: Polat, Y
– sequence: 3
  givenname: F M
  surname: Comu
  fullname: Comu, F M
– sequence: 4
  givenname: H
  surname: Kartal
  fullname: Kartal, H
– sequence: 5
  givenname: M
  surname: Arslan
  fullname: Arslan, M
– sequence: 6
  givenname: A
  surname: Kucuk
  fullname: Kucuk, A
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30160134$$D View this record in MEDLINE/PubMed
BookMark eNo1UDtPwzAY9FBEH7AxI48sgc-xk9gjVOUhRWKBOXKcz6qrJC6OI5p_TwRluTudTqfTrcmi9z0ScsPgXjChHp7KskqByQokLMgKAPJEpUIuyXoYDgCCZyy_JEsOLAfGxYrYnbVoIvWWGgxu7Kg_uQap7ymGKe6DN1NE2qD1odO1a12cqOtp0JG2_hsDxVMM2P3ag9nPStOARwx2HNzc4vrDGKYrcmF1O-D1mTfk83n3sX1NyveXt-1jmRieqpgYq7XgEjVII6wQWhW85gx4kTOZZrnJNNhcK2NF0zCFaSa45kxYsEyZmvMNufvrPQb_NeIQq25ehW2re_TjMJ-jikzJGebo7Tk61h021TG4Toep-v-G_wDt-Wdx
CitedBy_id crossref_primary_10_3390_molecules25194407
crossref_primary_10_1155_2022_3176455
crossref_primary_10_2147_IJN_S263001
crossref_primary_10_1007_s00210_024_03610_w
crossref_primary_10_3390_medicina60050752
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.4149/BLL_2018_080
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 30160134
Genre Journal Article
Comparative Study
GroupedDBID 2WC
53G
6RX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CGR
CUY
CVF
DIK
EBS
ECM
EIF
EJD
F5P
NPM
OK1
P2P
P6G
TR2
W2D
ZGI
0R~
7X8
AASML
ABDBE
AEFQL
AFDZB
SOJ
ID FETCH-LOGICAL-c329t-cfaa438ea08c4f44a973b31037618256c5a0f6a9cf4dd19e2543a314f0f19cb33
ISSN 0006-9248
IngestDate Fri Jul 11 01:09:29 EDT 2025
Wed Feb 19 02:44:35 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords erythrocyte deformability
ischemia reperfusion
cerium oxide rat
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c329t-cfaa438ea08c4f44a973b31037618256c5a0f6a9cf4dd19e2543a314f0f19cb33
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink http://www.elis.sk/download_file.php?product_id=5781&session_id=7akj3dccj1craa788rcob7gh03
PMID 30160134
PQID 2097598975
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2097598975
pubmed_primary_30160134
PublicationCentury 2000
PublicationDate 2018
20180101
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – year: 2018
  text: 2018
PublicationDecade 2010
PublicationPlace Slovakia
PublicationPlace_xml – name: Slovakia
PublicationTitle Bratislavské lékarské listy
PublicationTitleAlternate Bratisl Lek Listy
PublicationYear 2018
SSID ssj0043516
Score 2.1768136
Snippet Cerium oxide is the oxide form of cerium, which has protective effects in ischemia reperfusion (I/R) injury. The purpose of our study was to look into the...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 441
SubjectTerms Animals
Cerium - pharmacology
Erythrocyte Deformability - drug effects
Hindlimb - blood supply
Injections, Intraperitoneal
Male
Rats
Rats, Wistar
Reperfusion Injury - blood
Reperfusion Injury - prevention & control
Title Effect of cerium oxide on erythrocyte deformability in rat lower extremity ischemia reperfusion injury
URI https://www.ncbi.nlm.nih.gov/pubmed/30160134
https://www.proquest.com/docview/2097598975
Volume 119
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEBZtCiUvpaVXeqFC3xa3lqX18diTtElLHzaQNyPJI8ixdti1S5Jf3xnJdryhgbYvXiODZPR9O54ZzcHYm8xJZ_MKogr1gUg5UUTGgImSRFcqjZ0UjnKHv_9Idw_Ut8P54bXskta8tZd_zCv5H1RxDHGlLNl_QHacFAfwHvHFKyKM17_CuC89TJHhuFy3nDXnRxWQ_x9WF9QAwV60lBflFVMfBeuz_BD02Sl1R5uhZF7B0g-jlYt3mg4RYOW6dYiBPO42U6Y_EGGQRb_WJ-GIfXYafk_QQB6HkDqjp36h2xDDPUZj_0RreiL6fY7IsvNa9JVvdk-TWXCVPdE7JqZSlL6BERp2-YaY7UVj4FM2EZoqlL66LswVGm8Uor6_X9L0ZRxaPk1wPVt6YCVVyRO9T3SzePbw6Da7k2SZoJjPT1_3hk81qoq-N-74viEzghZ-N112m90dJrrZEPEKyeI-u9dbEvx9oMUDdgvqh8wFSvDG8UAJ7inBm5pPKME3KMGPao6wck8JPlKCD5TgE0rwQIlH7ODL58XH3ahvpRFZmRRtZJ3WSuag49wqp5QuMmmoxVyWooE5T-1cxy7VhXWqqkQBVCJBS6FcjP9ea6R8zLbqpoanjGciMVooAK2MAgEmlXFexICKq7E43w57PexQiaKKzp90DU23xu0ssnmR42WHPQlbV56FmirlsL_PbnzynG0THsH99YJttasOXqJC2JpXHtTfdV9h9w
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+cerium+oxide+on+erythrocyte+deformability+in+rat+lower+extremity+ischemia+reperfusion+injury&rft.jtitle=Bratislavsk%C3%A9+l%C3%A9karsk%C3%A9+listy&rft.au=Tatar%2C+T&rft.au=Polat%2C+Y&rft.au=Comu%2C+F+M&rft.au=Kartal%2C+H&rft.date=2018&rft.issn=0006-9248&rft.volume=119&rft.issue=7&rft.spage=441&rft_id=info:doi/10.4149%2FBLL_2018_080&rft_id=info%3Apmid%2F30160134&rft.externalDocID=30160134
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-9248&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-9248&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-9248&client=summon